Ventripoint Diagnostics

Ventripoint’s flagship product line—VMS+—uses proprietary AI to convert standard 2D echocardiography images into high-fidelity 3D models of all four heart chambers. The system provides volumetric and functional measurements with accuracy comparable to MRI but at a fraction of the cost and time. The latest version submitted for regulatory approval in Canada as of August 2024 features further workflow integration and magnet-free sensors. Clinical adoption has occurred across major hospitals in North America and Europe; the technology addresses key gaps such as right-heart assessment that are difficult with conventional ultrasound.